Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $709.76 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $369.16 | 18 | $0 (2024) |
| Alkermes, Inc. | $81.89 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $47.93 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $32.65 | 1 | $0 (2022) |
| Lundbeck LLC | $29.44 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $25.25 | 1 | $0 (2022) |
| Tris Pharma Inc | $23.29 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $22.78 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $21.19 | 1 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.60 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $253.94 | 9 | ABBVIE INC. ($167.69) |
| 2023 | $254.47 | 15 | ABBVIE INC. ($148.09) |
| 2022 | $201.35 | 9 | ABBVIE INC. ($53.38) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $118.30 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: CNS | ||||||
| 03/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PSYCHIATRY | ||||||
| 01/23/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: ADHD | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: CNS | ||||||
| 12/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: CNS | ||||||
| 08/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: CNS | ||||||
| 04/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 41 | 80 | $8,000 | $1,833 |
| 2021 | 4 | 127 | 468 | $48,925 | $22,891 |
| 2020 | 5 | 126 | 239 | $22,760 | $7,319 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 26 | 50 | $5,000 | $1,348 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 30 | $3,000 | $484.90 | 16.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 48 | 281 | $28,100 | $13,011 | 46.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 39 | 68 | $8,500 | $4,392 | 51.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 102 | $10,200 | $4,350 | 42.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 17 | $2,125 | $1,138 | 53.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 138 | $13,800 | $3,943 | 28.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 39 | $3,900 | $1,464 | 37.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 18 | 21 | $2,600 | $1,195 | 46.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 24 | $1,440 | $414.48 | 28.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 17 | $1,020 | $301.39 | 29.5% |
About Olivia Bonanno, CNP
Olivia Bonanno, CNP is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1720564735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Olivia Bonanno, CNP has received a total of $709.76 in payments from pharmaceutical and medical device companies, with $253.94 received in 2024. These payments were reported across 33 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($709.76).
As a Medicare-enrolled provider, Bonanno has provided services to 294 Medicare beneficiaries, totaling 787 services with total Medicare billing of $32,043. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Virginia Beach, VA
- Active Since 07/12/2018
- Last Updated 02/24/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1720564735
Products in Payments
- VRAYLAR (Drug) $369.16
- ARISTADA (Drug) $81.89
- REXULTI (Drug) $48.73
- TRINTELLIX (Drug) $47.93
- SPRAVATO (Drug) $32.65
- NUCALA (Biological) $25.25
- Dyanavel XR (Drug) $23.29
- Auvelity (Drug) $22.78
- INGREZZA (Drug) $21.19
- CAPLYTA (Drug) $20.60
- GRALISE (Drug) $16.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Virginia Beach
Genise Binns
Psychiatric/Mental Health — Payments: $10,066
Mrs. Nakeshia Mouzon, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $6,575
Mary Crutchfield, Pmhnp, Fnp, PMHNP, FNP
Psychiatric/Mental Health — Payments: $6,091
Mrs. Arnella Edwards
Psychiatric/Mental Health — Payments: $5,663
Jamie Deputy, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,582
Brittany Smith, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,301